Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2023 | 12-2022 | 06-2022 | 12-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,295 | -5,283 | -9,321 | -4,796 | -11,439 |
| Depreciation Amortization | 69 | 33 | 39 | -23 | 56 |
| Other Working Capital | -4,302 | -1,394 | 1,279 | 1,294 | -3,214 |
| Other Operating Activity | 40 | 117 | -948 | -2,793 | 1,648 |
| Operating Cash Flow | $-13,488 | $-6,527 | $-8,951 | $-6,318 | $-12,949 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -3 | -65 | -2 | -8 |
| Other Investing Activity | -20 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-25 | $-3 | $-65 | $-2 | $-8 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 84 | 8 | 11,829 | 11,906 | 27,412 |
| Financing Cash Flow | $84 | $8 | $11,829 | $11,906 | $27,412 |
| Exchange Rate Effect | 616 | 295 | 2,041 | 888 | -319 |
| Beginning Cash Position | 23,432 | 22,892 | 20,398 | 20,482 | 6,872 |
| End Cash Position | 10,619 | 16,665 | 25,252 | 26,956 | 21,008 |
| Net Cash Flow | $-12,813 | $-6,227 | $4,855 | $6,474 | $14,136 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,488 | -6,527 | -8,951 | -6,318 | -12,949 |
| Free Cash Flow | -13,488 | -6,527 | -8,951 | -6,318 | -12,949 |